Regulatory guidance to help your organization with response, remediation planning, and preventative measures.

Whether you’ve just been issued a 483 following FDA inspection or a warning letter due to a breach of FDA regulations, there is no time to delay. A point-by-point detailed response or remediation letter must be submitted immediately to avoid further penalty. From informative consulting to full-service strategy, let our regulatory experts help develop a customized plan for your FDA response needs.

Check out our case study about USDM Life Sciences supported a large scale remediation effort reassessing nearly 2,000 GxP software applications in the wake of unsavory FDA audit findings.

Areas of Focus

For Companies Under Agency Scrutiny

Sorry, no matches found.

Thought Leaders

Leading experts

Learn More

Bob Lucchesi

Vice President of Global Regulatory Compliance, Quality Assurance and Auditing

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.